The Third Xiangya Hospital of Central South University
The Third Xiangya Hospital of Central South University
Explore linked clinical trials.75 results ยท Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Online Tai Chi Versus Digital CBT-I for Chronic Insomnia: A Multicenter Randomized Noninferiority Trial | Chronic Insomnia Disorder | Not yet recruiting | Not applicable | 2026-10-02 | NCT07853651 | |
| Case Management for Microtia | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ear Diseases, microtia, otorhinolaryngologic disease | Recruiting | Not applicable | 2026-09-29 | NCT07846345 | |
| Safety, Tolerability, and Pharmacokinetics of DM1001 Transdermal Patch in Healthy Chinese Participants | Healthy Participants | Not yet recruiting | Phase 1 | 2026-09-28 | NCT07844954 | |
| Safety, Pharmacokinetics, and Pharmacodynamics of Continuous KL0011034 Infusion in Healthy Chinese Adults | General Anesthesia; Healthy Participants Study | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07841626 | |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HW243040 in Healthy Participants | Healthy Volunteers | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07841522 | |
| This Phase 1a Study Will Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Relative Bioavailability of Single-dose DMI019 Nasal Spray in Healthy Participants. | Healthy Volunteers | Not yet recruiting | Phase 1 | 2026-09-22 | NCT07833072 | |
| A Method Characterization Study to Evaluate Thermoregulatory Sweat Production in Healthy Volunteers and Patients With ROSAH Syndrome) | Hypohidrosis, Skin and Connective Tissue Diseases, anhidrosis, retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome, skin disorder, sweat gland disorder | Not yet recruiting | Not applicable | 2026-09-10 | NCT07814209 | |
| The Effect of Different Delivery Positions on Pelvic Floor Function. | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urinary Incontinence, Stress, Urination Disorders, Urogenital Diseases, Urological Manifestations, urinary system disorder | Not yet recruiting | Not applicable | 2026-09-10 | NCT07081321 | |
| Efficacy and Safety of HRS-9190 in General Anesthesia | Muscle Hypotonia, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder | Enrolling by invitation | Phase 3 | 2026-09-09 | NCT07733245 | |
| Thrombus Aspiration in STEMI Patients With High Thrombus Burden | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-09-09 | NCT04212494 | |
| A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0195 Injection in Participants With or Without Elevated Lipoprotein(a) | Elevated Lipoprotein(a) | Not yet recruiting | Phase 1 | 2026-09-04 | NCT07804160 | |
| Comparison of HBW-3220 Capsule Formulations and the Effect of Food in Healthy Participants | Healthy Volunteers | Not yet recruiting | Phase 1 | 2026-09-02 | NCT07799597 | |
| The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-02 | NCT07138755 | |
| ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC | Neoplasm, Residual, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Not stated | 2026-08-31 | NCT05198154 | |
| A Phase Ia Trial Comparing the Pharmacokinetics/Pharmacodynamics, Safety, and Preliminary Efficacy of HHK001 and Enantone in Patients With Endometriosis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, endometriosis, female reproductive system disorder | Not yet recruiting | Phase 1 | 2026-08-28 | NCT07793162 | |
| Couple-Coordinated Lifestyle Intervention for Women With a History of Gestational Diabetes Mellitus | Couples; Diabetes Prevention; GDM; Lifestyle Intervention; Postpartum | Not yet recruiting | Not applicable | 2026-08-13 | NCT07762625 | |
| A Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection in Participants With Moderate-to-Severe Non-Cancer Chronic Pain | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Phase 1 | 2026-08-07 | NCT07751094 | |
| A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio | Drug-Drug Interaction (DDI); Healthy Volunteers | Not yet recruiting | Phase 1 | 2026-08-04 | NCT07745439 | |
| Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 2 | 2026-07-28 | NCT07272499 | |
| Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, nervous system disorder, perceptual disorders | Active, not recruiting | Not applicable | 2026-07-28 | NCT03012971 | |
| A CSM-Based Volume Management Program for Chronic Heart Failure | Chronic Heart Failure | Not yet recruiting | Not applicable | 2026-07-07 | NCT07686536 | |
| Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Disease Progression, Neoplasms by Site, Pancreatic cancer, adult, Pathologic Processes, Pathological Conditions, Signs and Symptoms, anxiety disorder, benign neoplasm of pancreas, depressive disorder, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, psychiatric disorder | Recruiting | Not stated | 2026-06-29 | NCT07529626 | |
| Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study | AF Ablation Patients With Moderate+ FMR and Persistent AF | Enrolling by invitation | Not stated | 2026-06-18 | NCT07096219 | |
| Precision Antithrombotic Therapy | Embolism and Thrombosis, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic disease, ischemic stroke, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder, venous thromboembolism | Enrolling by invitation | Not stated | 2026-06-17 | NCT07654634 | |
| SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Recruiting | Phase 4 | 2026-06-17 | NCT07209787 |